Bioequivalence Study of Esomeprazole 20 Milligram (mg) Delayed-Release Capsules in Healthy Adult Participants
Condition: Gastrointestinal Diseases Interventions: Drug: Esomeprazole 20 mg Delayed-Release Capsules; Drug: Esomeprazole 20 mg Delayed-Release Capsules (Nexium 24HR) Sponsor: GlaxoSmithKline Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials